COFCO Bio-Chemical: Lysine Unit Price Decline and Cost Rise Affect Gross Margin Decline
-
Last Update: 2020-07-02
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
2012, the Company's operating income was RMB7.730 billion, up 4.45% YoY; net profit attributable to shareholders of listed companies was RMB183 million, down 48.46% YoY; and net profit attributable to shareholders of listed companies, net income after deducting non-recurring profit and loss, was RMB151 million, down 57.12% YoYIncreased sales led to revenue growth, while the rise in the price of raw materials and the fall in the price of finished products led to a reduction in profit marginsw2m
During the reporting period, the company's main business fuel ethanol, citric acid, lysine and other products technology level has been comprehensively improvedCitric acid, lysine products due to fierce competition in the market led to a decline in product prices, and raw material prices, technological progress can not be fully compensated, the overall impact of the gross margin decreased from the previous year;w2m
The company successfully completed the acquisition of COFCO Biochemical (Thailand) Co., Ltd., to promote the company's rational layout of the citric acid industry, is expected to complete the second half of 2013 technical reform to achieve productionw2m
The company's core business is fuel ethanol, citric acid, lysineAmong them, amino acids and their by-products and other aspects, operating cost income of 1.871 billion yuan, up 0.24% YoY; operating costs 15.40 million yuan, up 4.42% YoY; gross margin of 17.7%, 3.3% YoY, currently 60,000 tons of lysine saline technology upgrading, the technology will continue to be updated in 2013 to reduce lysine costsw2mthe company's operating income in 2012 was RMB7.730 billion, up 4.45% YoY; net profit attributable to shareholders of listed companies was RMB183 million, down 48.46% YoY; and net profit attributable to shareholders of listed companies, net profit after non-recurring profit and loss, decreased by 57.12% YoYIncreased sales led to revenue growth, while the rise in the price of raw materials and the fall in the price of finished products led to a reduction in profit marginsw2m
During the reporting period, the company's main business fuel ethanol, citric acid, lysine and other products technology level has been comprehensively improved Citric acid, lysine products due to fierce competition in the market led to a decline in product prices, and raw material prices, technological progress can not be fully compensated, the overall impact of the gross margin decreased from the previous year; w2m
The company successfully completed the acquisition of COFCO Biochemical (Thailand) Co., Ltd., to promote the company's rational layout of the citric acid industry, is expected to complete the second half of 2013 technical reform to achieve production w2m
The company's core business is fuel ethanol, citric acid, lysine Among them, amino acids and their by-products and other aspects, operating cost income of 1.871 billion yuan, up 0.24% YoY; operating costs 15.40 million yuan, up 4.42% YoY; gross margin of 17.7%, 3.3% YoY, currently 60,000 tons of lysine saline technology upgrading, the technology will continue to be updated in 2013 to reduce lysine costs w2m
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.